UroGen Pharma Ltd (URGN) last year’s performance of -47.61% is a clear signal for an entertaining trading season.
UroGen Pharma Ltd (NASDAQ: URGN) on Friday, plunged -5.88% from the previous trading day, before settling in for the closing price of $10.71. Within the